EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT.  Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.

Biotechnology

EvolveImmune Therapeutics

EvolveImmune Therapeutics' headquarters in Branford, CT, United States

The Farmington office focuses on research support and facilities management in a collaborative environment.

Farmington

Stephen Bloch

Jay Fine

Mark Aimone, MBA

Michael Franken M.D.

Jennifer Gabler

Louis Matis

Charles Fuchs

Ian Taylor

Sidi Chen

Nils Lonberg

Daguang Wang

Denis Patrick

Richard Flavell

Derek Yoon

Mario Sznol

Susan Kaech

The Research and Development team at EvolveImmune Therapeutics drives the innovation of novel immunotherapeutic molecules by leveraging cutting-edge in vivo target discovery platforms. Comprised of scientists and researchers of various specializations, the team focuses on identifying and optimizing therapeutic candidates to address unmet needs in oncology and autoimmune diseases, translating groundbreaking research into clinical applications.

Research and Development

This department focuses on advancing scientific knowledge through innovative research and experimentation.

Research Science

This department conducts research and development in the field of biotherapeutics to advance medical innovations.

Biotherapeutics Research

The Advisory Team at EvolveImmune Therapeutics comprises a group of experts who provide strategic guidance and insights on scientific research, clinical development, and regulatory strategies. Their collective expertise helps steer the company's efforts in developing groundbreaking immunotherapies for oncology and autoimmune diseases.

Advisory Team

This department oversees the strategic direction and governance of the organization.

Governance Affairs

The Directors and Senior Management team at EvolveImmune Therapeutics is responsible for strategic oversight and executive decision-making. They guide the company's research and development initiatives, manage key operations like CMC (Chemistry, Manufacturing, and Controls), and ensure the alignment of organizational goals with pioneering advancements in immunotherapy. This team leverages its expertise to steer the company towards impactful innovations in oncology and autoimmune disease treatments.

EvolveImmune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Research Science

Biotherapeutics Research

Advisory Team

Governance Affairs

Directors and Senior Management

Offices

EvolveImmune Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Research Science

Biotherapeutics Research

Advisory Team

Governance Affairs

Directors and Senior Management

Offices

Related companies